Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous low-dose ciclesonide vs intermittent treatment for exacerbations in children with mild asthma
2007-003736-34Phase 3Completed
- Sponsor
- Nycomed
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (3 arms), sponsored by Nycomed. Primary endpoint: Time to first asthma exacerbation. Started Jul 2007; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-003736-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003736-34.